View in EDS HTML Full Text PDF Full Text

Clinical Impact and Cost-Effectiveness of Updated 2023/24 COVID-19 mRNA Vaccination in High-Risk Populations in the United States.

Saved in:
Bibliographic Details
Title: Clinical Impact and Cost-Effectiveness of Updated 2023/24 COVID-19 mRNA Vaccination in High-Risk Populations in the United States.
Authors: Joshi, Keya1 (AUTHOR) Keya.Joshi@modernatx.com, Dronova, Mariia2 (AUTHOR) Mariia.Dronova@putassoc.com, Paterak, Ewelina2 (AUTHOR) Ewelina.Paterak@putassoc.com, Nguyen, Van H.3 (AUTHOR) vhnguyen@vhnconsulting.com, Kopel, Hagit1 (AUTHOR) Hagit.Kopel@modernatx.com, Mansi, James1 (AUTHOR) James.Mansi@modernatx.com, Van de Velde, Nicolas1 (AUTHOR) Nicolas.VandeVelde@modernatx.com, Beck, Ekkehard1 (AUTHOR) Ekkehard.Beck@modernatx.com
Source: Infectious Diseases & Therapy. Jun2025, Vol. 14 Issue 6, p1219-1238. 20p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:21938229
DOI:10.1007/s40121-025-01128-z